about
Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.Cisplatin-Associated Ototoxicity: A Review for the Health ProfessionalHeat shock protein-mediated protection against Cisplatin-induced hair cell death.Comparison of the effectiveness of monitoring Cisplatin-induced ototoxicity with extended high-frequency pure-tone audiometry or distortion-product otoacoustic emissionCisplatin ototoxicity affecting cochlear implant benefit.Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupLate effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.Treatment outcomes and late toxicities in patients with embryonal central nervous system tumorsAuditory complications in childhood cancer survivors: a report from the childhood cancer survivor studyRole of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsPharmacogenomics of cisplatin-induced ototoxicityCisplatin ototoxicity in rat cochlear organotypic cultures.Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort StudyHigher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentNeurological complications following treatment of children with brain tumors.Pharmacogenomics and active surveillance for serious adverse drug reactions in children.Cancer pharmacogenomics in children: research initiatives and progress to date.Medication associated with hearing loss: 25 years of medical malpractice cases in the United States.Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.Parents are aware of the ototoxic effects of chemotherapy in paediatrics undergoing cancer treatment - Professional versus parental views: A pilot study.Ototoxicity monitoring in children treated with platinum chemotherapy.Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig.Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.Treatment of childhood astrocytomas with irinotecan and cisplatin.Is there a gender-related susceptibility for cisplatin ototoxicity?Ototoxicity: A Challenge in Diagnosis and Treatment.The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.Economic impact of a genetic test for cisplatin-induced ototoxicity.Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
P2860
Q28391411-5574C8F7-6BB6-4F09-AAAC-9631ADE48E1CQ30365226-3101B8D7-2F6E-4F36-8787-CDA6702A69AAQ30392315-A6B8015B-9F52-442A-88E3-974B57F430BEQ30429268-2E563FB5-4730-48D7-8A8F-7E5D88629AB4Q30465304-BB4F8900-14F5-40C2-87DF-06D17F45FABFQ30544354-A1C6848E-13AE-46E5-8A57-EBF71FB2041AQ33629840-3162D2C0-D8B5-4167-A284-21BEC7743CC3Q33780411-8108FDE5-BD81-49A3-B451-D56B80A28465Q33882297-58559A22-A087-4BFC-930A-BDDEA933C32BQ33922193-EBB54796-C21E-4816-B5BE-F59FEA9C3D1CQ33924534-C14CDF28-0116-46E0-AB6B-A831A0258A07Q34667517-068CB672-5EA4-489C-8266-C63A16E66B7CQ34970231-94E99928-9971-4C05-B358-30D1B4474C0BQ35327266-0CF1FF58-C255-4CB7-B8CA-0981447F0058Q35553827-182EB4EE-7EC8-4E8B-98F6-47E700E29441Q35592843-FCB63311-1C30-437C-BE98-CAC67458A68CQ35692141-2ED8370F-7898-4AE9-93D1-AB5FA2A6E3A3Q36153146-6EF27EB7-8DD5-4361-8CC8-1932A2A93936Q36384257-4C17996C-0354-47C6-9692-732655A692B0Q36729469-D11E3969-40AC-4B4B-AE9B-40659EFF8D23Q37791154-DF43203F-4FBE-49A8-9BFA-40E8D3CFC989Q38093137-792CDF2C-9E9F-4DD0-9F2C-9E4B2768DCC3Q38217409-7CE11CDF-1768-4E56-9EBE-F382F4E7889EQ38738787-35801313-AC84-4DBC-ADFF-1919B3172F99Q38784807-20F882A2-2B8F-41DF-9C28-4D1DAED60445Q38818727-2693391A-0872-4B5B-BB89-764FF1AC7CC0Q38915210-6E868DE6-8474-4012-B3F1-A95BEC1550B3Q39453840-3EF7B439-AA7D-4080-B6A4-A1470C64D854Q42361422-5CEBFE15-38D8-4D89-A9C0-095C167E1781Q42439712-349C2D60-9872-4FF7-AFF8-855A59677B83Q46204838-016A5482-E363-45D4-A4EA-C3609206F1A1Q46256727-2E2B242B-384E-4FEA-AA1A-17A52E6434B7Q48204130-014CEA7B-D601-4A6E-AD6F-9425BC9E77FBQ48548440-96AC04F7-0043-44AE-9F13-80934EA8EE3FQ50300972-AB3249E2-8CD9-4C2F-9D09-0D050D4C638AQ50430194-A5914581-BA5C-4559-90E8-B4A2E875EA78Q50433278-B49C307A-7C45-4E6A-AC82-27341D451643Q50434327-69070729-37BA-4A93-96C9-AD08279F11CDQ53783738-8A86A1FC-10C6-4A83-86A0-B3C5C3C1458F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Ototoxicity from cisplatin therapy in childhood cancer.
@en
Ototoxicity from cisplatin therapy in childhood cancer.
@nl
type
label
Ototoxicity from cisplatin therapy in childhood cancer.
@en
Ototoxicity from cisplatin therapy in childhood cancer.
@nl
prefLabel
Ototoxicity from cisplatin therapy in childhood cancer.
@en
Ototoxicity from cisplatin therapy in childhood cancer.
@nl
P2093
P1476
Ototoxicity from cisplatin therapy in childhood cancer.
@en
P2093
Algemir L Brunetto
Letícia S Rosito
Luciana Cigana
Patrícia P Coradini
Simone G A Selistre
P304
P356
10.1097/MPH.0B013E318059C220
P577
2007-06-01T00:00:00Z